Economic Evaluation of Lecanemab for Early Symptomatic Alzheimer's Disease in South Korea
{{output}}
Background/objectives: Alzheimer's disease (AD) exerts a considerable economic burden on South Korea's aging population. Lecanemab, an amyloid-targeting therapy, has demonstrated efficacy in mitigating cognitive decline in earl... ...
